Brief: Adial Pharmaceuticals - As Of Aug 10, Anticipates Termination Of CEO Cary Claiborne After 2026 Annual Meeting

Azora Therapeutics

13/08/2026 22:35

Aug 13 (Reuters) - Adial Pharmaceuticals Inc ADIL.O:
ADIAL PHARMACEUTICALS - AS OF AUG 10, ANTICIPATES TERMINATION OF CEO CARY CLAIBORNE AFTER 2026 ANNUAL MEETING - SEC FILING
ADIAL PHARMACEUTICALS - ANTICIPATES MATTHEW DAVIDSON TO BE APPOINTED PRESIDENT AND CEO OF ADIAL PHARMACEUTICALS - SEC FILING
ADIAL PHARMACEUTICALS - ANTICIPATES TERMINATION OF CFO VINAY SHAH AFTER 2026 ANNUAL MEETING - SEC FILING
ADIAL PHARMACEUTICALS - ANTICIPATES BOARD CHANGES AND LEGACY MEMBER RESIGNATIONS AFTER STOCKHOLDER APPROVAL - SEC FILING
Further company coverage: ADIL.O

 ((Reuters.Briefs@thomsonreuters.com;))